Clinical
New clinical trial registered for Romiplostim
Related compound: RomiplostimView source →
Romiplostim N01 in the Treatment of Refractory Chemoradiotherapy-induced AA (NCT07532408) registered on ClinicalTrials.gov. Phase: phase 2. Status: not yet recruiting.